Advancing R&D with a scientific mindset and academic/business sense

webinar

Fri, 21 Sep 2018, 16:00 CEST (Berlin)

Dr. Guillermo Morales, PhD, MBA, CEO of Innoventyx

Advancing R&D with a scientific mindset and academic/business sense

How do you start a research program and advance it with the limited funds you have? This is a common problem we all face whether you are in industry or in academia. In drug discovery if you don’t have a way to know what compounds you should buy/make then your chances of success are the same as buying a lottery ticket. And even if you have a promising hit/lead compound, how will you improve it? How much should you improve it? And to what end? A publication, patent filing, grant application? In this webinar Dr. Morales will cover these points, foundations to tackle obstacles and make decisions to start and advance research projects.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on